Zealand Pharma A/s Stock
€61.80
Your prediction
Zealand Pharma A/s Stock
Pros and Cons of Zealand Pharma A/s in the next few years
Pros
Cons
Performance of Zealand Pharma A/s vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Zealand Pharma A/s | 0.000% | -4.894% | -8.172% | -35.524% | -3.407% | 127.039% | - |
| Saniona AB | 0.630% | 4.099% | 11.303% | 193.313% | 0.626% | 626.930% | -4.218% |
| Actinium Pharmaceuticals Inc. | 3.890% | -14.233% | -6.467% | -16.341% | -4.143% | -87.782% | -82.062% |
| NanoViricides Inc. | 9.680% | -10.577% | -1.587% | -34.507% | - | -11.597% | -60.593% |
News
Why 2026 Could Be Another Breakout Year for Rocket Lab
The momentum has shown little sign of slowing for Rocket Lab (NASDAQ: RKLB). Shares of the aerospace and defense company have gone from strength to strength, rising roughly 1,775% over the past
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders
BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New
Why Rocket Lab Stock Keeps Going Up
Rocket Lab (NASDAQ: RKLB) stock rocketed to a 10th straight day of gains Friday, surging 5.7% through 11:15 a.m. ET after announcing the New Zealand-based space company announced yet another big


